Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin effects on HDL2 and reverse cholesterol transport in Chinese patients with coronary artery disease and hyperlipidemia
ChiCTR-IPR-15007184Phase 4Not yet recruiting
- Sponsor
- Army Specialized Medical Center
- Start
- Oct 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rosuvastatin in coronary arteriosclerosis and hyperlipidemia (2 arms), sponsored by Army Specialized Medical Center. Primary endpoint: HDL subfractions. Planned start Oct 2015; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
coronary arteriosclerosishyperlipidemia
Beyond the preview
Go deeper on ChiCTR-IPR-15007184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007184.